CA
NZ
UK
AU
IND
US
Key HighlightsUniversal Logistics (NASDAQ:ULH) reported third quarter 2026Net Incomeof USD 18.1 million, or USD 0.69 per share, against a net loss of USD 117.9 million, or USD 4.48 per share, a year earlier.Shares rose about 30% on October 30, 2026, according to published market …
Key HighlightsACCO Brands (NYSE:ACCO) reported third quarter adjustedEarningsof USD 0.28 per share on October 29, 2026, up from USD 0.21, withTariffrefunds adding USD 0.11 to diluted earnings.Net sales fell 0.9% to USD 380.3 million and comparable sales dropped 6.2%, so the earnings gain came …
Key HighlightsRimini Street (NASDAQ:RMNI) reported third quarter 2026Revenueof USD 112.1 million on October 29, 2026, up 8.3% from USD 103.4 million, with adjusted revenue excluding PeopleSoft up 10.7%.Adjusted EBITDA rose 52.0% to USD 15.1 million, andNet Incomereached USD 6.5 million, or USD 0.07 per …
CareDx sells blood tests that monitor transplant recipients for signs of organ rejection, using donor derived cell free DNA to detect injury early. Published coverage says about USD 15 million of Testing Services revenue came from tests run in earlier periods, compared with USD …
Civeo rents workforce accommodation rooms to resource projects, so revenue depends on billed rooms and daily rates. The new guidance lifts adjusted EBITDA to USD 89 million to USD 92 million from USD 85 million to USD 90 million, raises capital spending to USD …
The company now expects adjusted revenue of about USD 3.42 billion, Michael Kors revenue of about USD 2.77 billion and Jimmy Choo revenue of about USD 650 million. Third quarter guidance is for revenue of about USD 1.005 billion, which includes the USD 20 …
A high price to earnings multiple capitalizes expected growth, so a guide that points to slower growth can reduce the multiple even when the quarter is strong. Management said the smaller beat came mainly from a modest slowdown in messaging, the company's largest product, …
Commercial Services depends on a small number of large rental car customers. A pre-earnings preview dated October 22, 2026 described how the renewed contract with Avis Budget Group carries lower pricing that flows through the segment starting in the third quarter. The renewal with …
The REMS question traces to thalassemia. In those trials, 5 of 301 patients had liver injury, 2 of them serious. Mitapivat has been sold for thalassemia under theBrandAQVESME since late January, only under a REMS, according to published coverage. Agios reports no sickle cell …
The weak spot was joint replacement. Hip sales fell 1% while knee sales rose 1.1%, whereas Johnson & Johnson (NYSE:JNJ) reported knee growth of 2.5% and hip growth of 3.2% in the same period, according to published coverage. Lobo said it is now clear …
Please wait processing your request...